Daily News Podcast

Mobile contraception app gets FDA approval

Publish date: August 14, 2018

 

The FDA approves the Natural Cycles mobile app as a form of contraception. Also today, on-demand PrEP has similar efficacy as daily PrEP for HIV prevention, continuation and complication rates are similar for implants and IUDs, and the CMS pushes ACOs to take on more risk. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

E-cigarettes: Prices down, sales up
MDedge Hematology and Oncology
No meaningful decline in opioid use
MDedge Hematology and Oncology
FDA warns against azithromycin in blood or lymph node cancers
MDedge Hematology and Oncology
Fibrosis progression linked to weight
MDedge Hematology and Oncology
FDA warns about azithromycin in some cancers
MDedge Hematology and Oncology
Concerns over CMS E/M payment proposal
MDedge Hematology and Oncology
Stigma for drug users with HCV
MDedge Hematology and Oncology
Inducing labor earlier reduced c-section rate
MDedge Hematology and Oncology
Autotransplant is linked to higher AML, MDS risk
MDedge Hematology and Oncology
Second-hand smoke sends teens to ED
MDedge Hematology and Oncology